Cargando…
Smoking is associated with pneumonia development in lung cancer patients
BACKGROUND: Various host factors can promote pneumonia susceptibility of lung cancer patients. However, data about risk factors for pneumonia in lung cancer patients receiving active treatments such as chemotherapy, radiotherapy, and surgical intervention are limited. Thus, the purpose of this study...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195765/ https://www.ncbi.nlm.nih.gov/pubmed/32357887 http://dx.doi.org/10.1186/s12890-020-1160-8 |
_version_ | 1783528604978642944 |
---|---|
author | Heo, Jung Won Yeo, Chang Dong Park, Chan Kwon Kim, Sung Kyoung Kim, Ju Sang Kim, Jin Woo Kim, Seung Joon Lee, Sang Haak Kang, Hye Seon |
author_facet | Heo, Jung Won Yeo, Chang Dong Park, Chan Kwon Kim, Sung Kyoung Kim, Ju Sang Kim, Jin Woo Kim, Seung Joon Lee, Sang Haak Kang, Hye Seon |
author_sort | Heo, Jung Won |
collection | PubMed |
description | BACKGROUND: Various host factors can promote pneumonia susceptibility of lung cancer patients. However, data about risk factors for pneumonia in lung cancer patients receiving active treatments such as chemotherapy, radiotherapy, and surgical intervention are limited. Thus, the purpose of this study was to identify risk factors for pneumonia development in lung cancer patients. METHODS: The present study used a lung cancer cohort of the Catholic Medical Center at the Catholic University of Korea from January 2015 to December 2018. Pneumonia was defined by the presence of a new or progressive infiltration on chest imaging together with any of the following: new onset purulent sputum, change in character of chronic sputum, and fever. We ruled out noninfectious infiltration such as drug or radiation toxicity and hydrostatic pulmonary edema. We especially excluded those if computed tomography revealed sharp demarcation consolidation or ground glass opacity limited radiation field. RESULTS: A total of 413 patients were enrolled in this study. Pneumonia occurred in 118 (28.6%) patients. The pneumonia group had significantly worse overall survival (OS) than the non-pneumonia group (456.7 ± 35.0 days vs. 813.4 ± 36.1 days, log rank p < 0.001). In patients with pneumonia, OS was shorter in ex-smokers and current smokers than in never smokers (592.0 ± 101.0 days vs. 737.0 ± 102.8 days vs. 1357.0 days, log rank p < 0.001). Age (hazard ratio [HR]: 1.046; 95% confidence interval [CI]: 1.019–1.074; p = 0.001), clinical stage IV (HR: 1.759; 95% CI: 1.004–3.083; p = 0.048), neutropenia (HR: 2.620; 95% CI: 1.562–4.396; p < 0.001], and smoking (HR: 2.040; 95% CI: 1.100–3.784; p = 0.024) were independent risk factors of pneumonia development in lung cancer patients in multivariate analysis. In subgroup analysis for patients treated with chemotherapy, age (HR: 1.043; 95% CI: 1.012–1.074; p = 0.006), neutropenia (HR: 3.199; 95% CI: 1.826–5.605; p < 0.001), and smoking (HR: 2.125; 95% CI: 1.071–4.216; p = 0.031) were independent risk factors of pneumonia development. CONCLUSIONS: Smoking and neutropenia were risk factors affecting pneumonia development in the total group and subgroup of patients with lung cancer. |
format | Online Article Text |
id | pubmed-7195765 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-71957652020-05-06 Smoking is associated with pneumonia development in lung cancer patients Heo, Jung Won Yeo, Chang Dong Park, Chan Kwon Kim, Sung Kyoung Kim, Ju Sang Kim, Jin Woo Kim, Seung Joon Lee, Sang Haak Kang, Hye Seon BMC Pulm Med Research Article BACKGROUND: Various host factors can promote pneumonia susceptibility of lung cancer patients. However, data about risk factors for pneumonia in lung cancer patients receiving active treatments such as chemotherapy, radiotherapy, and surgical intervention are limited. Thus, the purpose of this study was to identify risk factors for pneumonia development in lung cancer patients. METHODS: The present study used a lung cancer cohort of the Catholic Medical Center at the Catholic University of Korea from January 2015 to December 2018. Pneumonia was defined by the presence of a new or progressive infiltration on chest imaging together with any of the following: new onset purulent sputum, change in character of chronic sputum, and fever. We ruled out noninfectious infiltration such as drug or radiation toxicity and hydrostatic pulmonary edema. We especially excluded those if computed tomography revealed sharp demarcation consolidation or ground glass opacity limited radiation field. RESULTS: A total of 413 patients were enrolled in this study. Pneumonia occurred in 118 (28.6%) patients. The pneumonia group had significantly worse overall survival (OS) than the non-pneumonia group (456.7 ± 35.0 days vs. 813.4 ± 36.1 days, log rank p < 0.001). In patients with pneumonia, OS was shorter in ex-smokers and current smokers than in never smokers (592.0 ± 101.0 days vs. 737.0 ± 102.8 days vs. 1357.0 days, log rank p < 0.001). Age (hazard ratio [HR]: 1.046; 95% confidence interval [CI]: 1.019–1.074; p = 0.001), clinical stage IV (HR: 1.759; 95% CI: 1.004–3.083; p = 0.048), neutropenia (HR: 2.620; 95% CI: 1.562–4.396; p < 0.001], and smoking (HR: 2.040; 95% CI: 1.100–3.784; p = 0.024) were independent risk factors of pneumonia development in lung cancer patients in multivariate analysis. In subgroup analysis for patients treated with chemotherapy, age (HR: 1.043; 95% CI: 1.012–1.074; p = 0.006), neutropenia (HR: 3.199; 95% CI: 1.826–5.605; p < 0.001), and smoking (HR: 2.125; 95% CI: 1.071–4.216; p = 0.031) were independent risk factors of pneumonia development. CONCLUSIONS: Smoking and neutropenia were risk factors affecting pneumonia development in the total group and subgroup of patients with lung cancer. BioMed Central 2020-05-01 /pmc/articles/PMC7195765/ /pubmed/32357887 http://dx.doi.org/10.1186/s12890-020-1160-8 Text en © The Author(s). 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Heo, Jung Won Yeo, Chang Dong Park, Chan Kwon Kim, Sung Kyoung Kim, Ju Sang Kim, Jin Woo Kim, Seung Joon Lee, Sang Haak Kang, Hye Seon Smoking is associated with pneumonia development in lung cancer patients |
title | Smoking is associated with pneumonia development in lung cancer patients |
title_full | Smoking is associated with pneumonia development in lung cancer patients |
title_fullStr | Smoking is associated with pneumonia development in lung cancer patients |
title_full_unstemmed | Smoking is associated with pneumonia development in lung cancer patients |
title_short | Smoking is associated with pneumonia development in lung cancer patients |
title_sort | smoking is associated with pneumonia development in lung cancer patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195765/ https://www.ncbi.nlm.nih.gov/pubmed/32357887 http://dx.doi.org/10.1186/s12890-020-1160-8 |
work_keys_str_mv | AT heojungwon smokingisassociatedwithpneumoniadevelopmentinlungcancerpatients AT yeochangdong smokingisassociatedwithpneumoniadevelopmentinlungcancerpatients AT parkchankwon smokingisassociatedwithpneumoniadevelopmentinlungcancerpatients AT kimsungkyoung smokingisassociatedwithpneumoniadevelopmentinlungcancerpatients AT kimjusang smokingisassociatedwithpneumoniadevelopmentinlungcancerpatients AT kimjinwoo smokingisassociatedwithpneumoniadevelopmentinlungcancerpatients AT kimseungjoon smokingisassociatedwithpneumoniadevelopmentinlungcancerpatients AT leesanghaak smokingisassociatedwithpneumoniadevelopmentinlungcancerpatients AT kanghyeseon smokingisassociatedwithpneumoniadevelopmentinlungcancerpatients |